Literature DB >> 16708070

Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized.

Thierry Bienvenu1, Jamel Chelly.   

Abstract

The discovery that Rett syndrome is caused by mutations that affect the methyl-CpG-binding protein MeCP2 provided a major breakthrough in understanding this severe neurodevelopmental disorder. Animal models and expression studies have contributed to defining the role of MeCP2 in development, highlighting its contribution to postnatal neuronal morphogenesis and function. Furthermore, in vitro assays and microrray studies have delineated the potential molecular mechanisms of MeCP2 function, and have indicated a role in the transcriptional silencing of specific target genes. As well as unravelling the mechanisms that underlie Rett syndrome, these studies provide more general insights into how DNA-methylation patterns are recognized and translated into biological outcomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708070     DOI: 10.1038/nrg1878

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  127 in total

1.  Differential effect of postnatal lead exposure on gene expression in the hippocampus and frontal cortex.

Authors:  J S Schneider; W Mettil; D W Anderson
Journal:  J Mol Neurosci       Date:  2011-12-10       Impact factor: 3.444

Review 2.  Dynamic epigenetic regulation in neurons: enzymes, stimuli and signaling pathways.

Authors:  Antonella Riccio
Journal:  Nat Neurosci       Date:  2010-11       Impact factor: 24.884

3.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 4.  Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.

Authors:  Jeffrey C Hansen; Rajarshi P Ghosh; Christopher L Woodcock
Journal:  IUBMB Life       Date:  2010-10       Impact factor: 3.885

5.  Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.

Authors:  Tatiana Nikitina; Xi Shi; Rajarshi P Ghosh; Rachel A Horowitz-Scherer; Jeffrey C Hansen; Christopher L Woodcock
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

6.  Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice.

Authors:  Georg M Stettner; Peter Huppke; Cornelia Brendel; Diethelm W Richter; Jutta Gärtner; Mathias Dutschmann
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

Review 7.  Epigenetic mechanisms of chronic pain.

Authors:  Giannina Descalzi; Daigo Ikegami; Toshikazu Ushijima; Eric J Nestler; Venetia Zachariou; Minoru Narita
Journal:  Trends Neurosci       Date:  2015-03-09       Impact factor: 13.837

8.  Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice.

Authors:  Valerie Matagne; Joyce Wondolowski; Matthew Frerking; Mohammad Shahidullah; Nicholas A Delamere; Ursula S Sandau; Sarojini Budden; Sergio R Ojeda
Journal:  Brain Res       Date:  2018-06-12       Impact factor: 3.252

9.  A de novo apparently balanced translocation [46,XY,t(2;9)(p13;p24)] interrupting RAB11FIP5 identifies a potential candidate gene for autism spectrum disorder.

Authors:  Jasmin Roohi; David H Tegay; John C Pomeroy; Sandra Burkett; Gary Stone; Roscoe Stanyon; Eli Hatchwell
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-06-05       Impact factor: 3.568

10.  Correcting deregulated Fxyd1 expression ameliorates a behavioral impairment in a mouse model of Rett syndrome.

Authors:  Valerie Matagne; Sarojini Budden; Sergio R Ojeda; Jacob Raber
Journal:  Brain Res       Date:  2012-12-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.